Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 6/20 | 0.74 |
| ▸ | CNR2 | P34972 | 5/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | MAPT | P10636 | 4/20 | 0.65 |
| ▸ | HPGD | P15428 | 4/20 | 0.65 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.65 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.65 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.65 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.65 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.65 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.65 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.65 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.65 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.65 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.65 |
| ▸ | PSMA5 | P28066 | 2/20 | 0.65 |
| ▸ | PSMB4 | P28070 | 2/20 | 0.65 |
| ▸ | PSMB6 | P28072 | 2/20 | 0.65 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.65 |
| ▸ | PSMB10 | P40306 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2678363 | 1.00 | CNR1 (0.74) | CNR1CNR2ALDH1A1MAPTHPGD | |
| SCHEMBL10602106 | 0.94 | CNR1 (0.66) | CNR1CNR2ALDH1A1MAPTHPGD | |
| SCHEMBL17614783 | 0.89 | CNR1 (0.71) | CNR1CNR2ALDH1A1MAPTHPGD | |
| SCHEMBL2676872 | 0.89 | CNR1 (0.71) | CNR1CNR2ALDH1A1MAPTHPGD | |
| SCHEMBL2676870 | 0.89 | CNR1 (0.71) | CNR1CNR2ALDH1A1MAPTHPGD | |
| SCHEMBL11195217 | 0.87 | KMT2A (0.56) | CNR1CNR2ALDH1A1PSMB11PSMA7 | |
| SCHEMBL15021864 | 0.86 | CNR1 (0.67) | CNR1CNR2ALDH1A1MAPTHPGD | |
| SCHEMBL1824277 | 0.85 | CNR1 (0.54) | CNR1CNR2ALDH1A1MAPTHPGD | |
| SCHEMBL5943469 | 0.85 | CNR1 (0.54) | CNR1CNR2ALDH1A1MAPTHPGD | |
| SCHEMBL17716482 | 0.85 | CNR1 (0.60) | CNR1CNR2ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210169905-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. | 2021-06-10 | — | — | US | disclosed |
| US-20200046738-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. | 2020-02-13 | — | — | US | disclosed |
| US-20180325923-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. | 2018-11-15 | — | — | US | disclosed |
| EP-2315740-B1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS INC (US) | 2017-10-25 | — | — | EP | disclosed |
| EP-2813486-B1 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS INC (US) | 2017-10-25 | — | — | EP | disclosed |
| US-20170246193-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. | 2017-08-31 | — | — | US | disclosed |
| US-9708245-B2 | Fatty acid acylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2017-07-18 | — | — | US | disclosed |
| US-9458094-B2 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2016-10-04 | — | — | US | disclosed |
| US-20160083336-A1 | FATTY ACID ACYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. | 2016-03-24 | — | — | US | disclosed |
| US-9272984-B2 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2016-03-01 | — | — | US | disclosed |
| US-8735378-B2 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2014-05-27 | — | — | US | disclosed |
| US-8735379-B2 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2014-05-27 | — | — | US | disclosed |
| US-8729293-B2 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2014-05-20 | — | — | US | disclosed |
| US-20120238585-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-09-20 | — | — | US | disclosed |
| US-20120238756-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-09-20 | — | — | US | disclosed |
| US-20120238530-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-09-20 | — | — | US | disclosed |
| US-20120238586-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-09-20 | — | — | US | disclosed |
| US-8173831-B2 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-05-08 | — | — | US | disclosed |
| US-20100184730-A1 | Fatty Acid Acylated Salicylates and Their Uses | CATABASIS PHARMACEUTICALS, INC. | 2010-07-22 | — | — | US | disclosed |
| US-20100041748-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200046738-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | CNR1 984/4885CNR2 505/4885ALDH1A1 285/4885 |
| US-20120238585-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | CNR1 984/4885CNR2 505/4885ALDH1A1 285/4885 |
| US-20180325923-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | CNR1 984/4885CNR2 505/4885ALDH1A1 285/4885 |
| US-20120238586-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | CNR1 984/4885CNR2 505/4885ALDH1A1 285/4885 |
| US-20170246193-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | CNR1 984/4885CNR2 505/4885ALDH1A1 285/4885 |
| US-20100041748-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | CNR1 984/4885CNR2 505/4885ALDH1A1 285/4885 |
| US-20210169905-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | CNR1 984/4885CNR2 505/4885ALDH1A1 285/4885 |
| US-20120238756-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | CNR1 984/4885CNR2 505/4885ALDH1A1 285/4885 |
| US-20160083336-A1 | FATTY ACID ACYLATED SALICYLATES AND THEIR USES | FADS1, FASN, ALOX5 | CNR1 1031/4885CNR2 438/4885ALDH1A1 230/4885 |
| US-20120238530-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | CNR1 984/4885CNR2 505/4885ALDH1A1 285/4885 |
| US-20100184730-A1 | Fatty Acid Acylated Salicylates and Their Uses | FADS1, FASN, ALOX5 | CNR1 1031/4885CNR2 438/4885ALDH1A1 230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.